Welcome to PrECOG

PrECOG is a research company that focuses on cancer clinical trials.  PrECOG, in conjunction with industry partners, develops clinical trials in all areas of oncology.  PrECOG, LLC was formed in 2006 by the Eastern Cooperative Oncology Group (ECOG). PrECOG’s main purpose is to sponsor clinical trials that enhance the scientific program of ECOG by creating an expedited system to perform Phase II adult oncology clinical trials through a faster, more nimble mechanism as a prelude to ECOG. PrECOG is the preferred mechanism for rapid piloting of investigational arms for future Phase III Cooperative Group trials through PrECOG. 

About PrECOG

PrECOG has the experience to provide full service clinical trial oversight and management of all key facets of sponsor related responsibilities under an IND. PrECOG has master contracts with an established premier network of institutions that allow for a more efficient study start-up, streamlined processes throughout the continuum of study operations. Strong existing site relationships to facilitate study start-up, and expedited timelines for data collection. PrECOG personnel work closely with ECOG sites, and have a strong working knowledge of their site operations. Unlike ECOG, PrECOG is solely funded outside of the public health system and utilizes a separate structure from ECOG for all facets of clinical trials operations, including site selection, data management, regulatory, and reporting.

PrECOG is governed by a Board of Managers. This Board is comprised of a Director of Operations and six members of the senior leadership of ECOG, each of whom are prominent in the institutions to which they are primarily affiliated. The six members of the ECOG senior leadership consist of two ex-officio ECOG officers, and four representatives of the constituencies of ECOG (Disease Committee Chairs, Community Clinical Oncology Programs, and Cooperative Group Outreach Programs). The operational links between PrECOG and the disease committees of ECOG, and the requirement for committee endorsement of all clinical trials in particular diseases, ensures that the ideas to be tested in PrECOG studies will be of the highest relevance for the development of improved cancer therapy. 

Members

User Name:
Password:
Remember Password
Request Login
Forgot Password

PrECOG News

PrECOG has a standing Data Safety Monitoring Board read more

PrECOG provides ECOG enrollment credit read more

 





Protocols

PrE0501
Enrollment is now closed for this protocol

Study of Vandetanib Combined with Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer

Designed by: DiSab Design, LLC